Inamed Obesity, Breast Implant, Facial Aesthetics Sales Spur Strong Q3

Data on Inamed's next-generation silicone breast implant could allay concerns voiced by FDA's General & Plastic Surgery Devices Panel about the controversial device category, the firm maintains

More from Archive

More from Medtech Insight